GlassScriptPhysician profile
Mary Spratt
NPI 1124028451
$1,497.27
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.76 · 2022: $468 · 2023: $936 · 2024: $54.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $243.27 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $154.62 | 2022-2023 | Odomzo, Blu-U, Levulan Kerastick |
| Janssen Biotech, INC. | $148.10 | 2022-2023 | Tremfya |
| Genzyme Corporation | $137.18 | 2021-2023 | |
| Dermavant Sciences, INC. | $99.85 | 2023 | Vtama |
| Amgen INC. | $95.64 | 2022-2023 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $92.36 | 2022-2023 | Sotyktu |
| Leo Pharma INC. | $87.76 | 2022-2023 | Adbry |
| Incyte Corporation | $72.26 | 2022-2023 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $61.03 | 2023 | Dupixent, Libtayo |
| Pfizer INC. | $57.93 | 2022-2024 | |
| Lilly USA, LLC | $55.47 | 2023 | Taltz |
| Novartis Pharmaceuticals Corporation | $54.46 | 2021-2024 | |
| Biofrontera INC. | $46.37 | 2022-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Arcutis Biotherapeutics, INC. | $31.80 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.99 | 2023 | Cyltezo |
| Blueprint Medicines Corporation | $19.15 | 2022 | |
| Ucb, INC. | $17.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Spratt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.